KR101490730B1 - 대사 증후군의 예방, 개선 또는 치료용 조성물 - Google Patents

대사 증후군의 예방, 개선 또는 치료용 조성물 Download PDF

Info

Publication number
KR101490730B1
KR101490730B1 KR1020127033286A KR20127033286A KR101490730B1 KR 101490730 B1 KR101490730 B1 KR 101490730B1 KR 1020127033286 A KR1020127033286 A KR 1020127033286A KR 20127033286 A KR20127033286 A KR 20127033286A KR 101490730 B1 KR101490730 B1 KR 101490730B1
Authority
KR
South Korea
Prior art keywords
hesperidin
caffeine
group
composition
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020127033286A
Other languages
English (en)
Korean (ko)
Other versions
KR20130029415A (ko
Inventor
타츠야 오하라
코타로 무로야마
신지 무로사키
요시히로 야마모토
Original Assignee
하우스 웰니스 푸드 코퍼레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 하우스 웰니스 푸드 코퍼레이션 filed Critical 하우스 웰니스 푸드 코퍼레이션
Publication of KR20130029415A publication Critical patent/KR20130029415A/ko
Application granted granted Critical
Publication of KR101490730B1 publication Critical patent/KR101490730B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
KR1020127033286A 2010-05-24 2011-01-14 대사 증후군의 예방, 개선 또는 치료용 조성물 Active KR101490730B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2010-118051 2010-05-24
JP2010118051A JP5564330B2 (ja) 2010-05-24 2010-05-24 メタボリックシンドロームの予防、改善または治療用組成物
PCT/JP2011/050495 WO2011148657A1 (ja) 2010-05-24 2011-01-14 メタボリックシンドロームの予防、改善または治療用組成物

Publications (2)

Publication Number Publication Date
KR20130029415A KR20130029415A (ko) 2013-03-22
KR101490730B1 true KR101490730B1 (ko) 2015-02-06

Family

ID=45003652

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020127033286A Active KR101490730B1 (ko) 2010-05-24 2011-01-14 대사 증후군의 예방, 개선 또는 치료용 조성물

Country Status (4)

Country Link
US (3) US20130096075A1 (enExample)
JP (1) JP5564330B2 (enExample)
KR (1) KR101490730B1 (enExample)
WO (1) WO2011148657A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6034107B2 (ja) * 2012-09-25 2016-11-30 日本メナード化粧品株式会社 幹細胞から褐色脂肪細胞への分化促進剤
JP6453534B2 (ja) * 2012-09-28 2019-01-16 小林製薬株式会社 脂質代謝促進剤
TWI705132B (zh) 2015-10-08 2020-09-21 日商三菱瓦斯化學股份有限公司 半導體元件之洗淨用液體組成物、半導體元件之洗淨方法及半導體元件之製造方法
WO2018074929A2 (en) 2016-10-20 2018-04-26 Rijksuniversiteit Groningen Drugs mimicking calorie restriction and tools and methods for identifying the same
JP6667773B1 (ja) * 2018-12-20 2020-03-18 公益財団法人 佐賀県地域産業支援センター 炎症性サイトカイン産生抑制用の組成物
JP7350304B2 (ja) * 2019-10-18 2023-09-26 国立大学法人徳島大学 アレルギー性の鼻炎症状抑制剤
JP7224008B1 (ja) 2022-08-30 2023-02-17 株式会社東洋新薬 経口組成物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006067866A1 (ja) * 2004-12-24 2006-06-29 Toyo Shinyaku Co., Ltd. プロアントシアニジン含有組成物
WO2008143182A1 (ja) * 2007-05-17 2008-11-27 Kaneka Corporation 甘草ポリフェノールを含有する組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4676040B2 (ja) * 1997-07-31 2011-04-27 株式会社林原生物化学研究所 組成物
JP4179765B2 (ja) * 2001-07-19 2008-11-12 花王株式会社 脂質代謝改善剤
JP2004035417A (ja) * 2002-06-28 2004-02-05 Kao Corp 血中総ケトン体濃度上昇剤
JP2005047839A (ja) * 2003-07-31 2005-02-24 Toyo Shinyaku:Kk プロアントシアニジン含有組成物
JP2008156341A (ja) * 2006-12-01 2008-07-10 Daiichi Sankyo Healthcare Co Ltd ウエスト周囲径低下剤
CA2686419A1 (en) * 2007-05-04 2008-11-13 Nutraceutic Et Business Consulting Composition having lipolytic activity, production method thereof and use of the composition
JP5121308B2 (ja) * 2007-05-28 2013-01-16 ハウスウェルネスフーズ株式会社 メタボリックシンドロームの予防、改善または治療組成物
JP5517421B2 (ja) * 2007-08-03 2014-06-11 花王株式会社 容器詰飲料
EP2226071B1 (en) * 2007-12-28 2016-04-13 Daicel Corporation Composition for oral administration

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006067866A1 (ja) * 2004-12-24 2006-06-29 Toyo Shinyaku Co., Ltd. プロアントシアニジン含有組成物
WO2008143182A1 (ja) * 2007-05-17 2008-11-27 Kaneka Corporation 甘草ポリフェノールを含有する組成物

Also Published As

Publication number Publication date
US20180264020A1 (en) 2018-09-20
KR20130029415A (ko) 2013-03-22
JP5564330B2 (ja) 2014-07-30
US9993493B2 (en) 2018-06-12
US20130096075A1 (en) 2013-04-18
JP2011246355A (ja) 2011-12-08
US20150265645A1 (en) 2015-09-24
WO2011148657A1 (ja) 2011-12-01

Similar Documents

Publication Publication Date Title
US20180264020A1 (en) Composition for prevention, amelioration or treatment of metabolic syndrome
JP5121308B2 (ja) メタボリックシンドロームの予防、改善または治療組成物
KR101700016B1 (ko) 근위축 억제제
JP6112895B2 (ja) メタボリックシンドロームの予防、改善または治療用組成物
KR101811210B1 (ko) 마가목 열매 추출물을 유효성분으로 하는 당뇨 질환 치료, 개선 또는 예방용 조성물
EP1656943A1 (en) Extract from plant of japanese parsley family and process for producing the same
JP2012001516A (ja) 脂質・糖質代謝改善作用を有するハトムギタンパク質含有組成物
EP2939672B1 (en) Igf-1 production promoter
JP2009046446A (ja) 免疫賦活剤
JP6772064B2 (ja) ポリフェノール含有機能性経口組成物
JP4022350B2 (ja) コレステロール上昇抑制作用およびｈｄｌ−コレステロール低下抑制作用を有する組成物
KR101890853B1 (ko) 프로타민 및 키토올리고당을 포함하는 비만의 예방 또는 치료용 조성물
US20070092587A1 (en) Extract from plant of japanese parsley family and process for producing the same
KR102955765B1 (ko) Cid16020046의 체중감소 효능과 비만치료제로 적용
KR101293032B1 (ko) 다시마 및 부티르산 나트륨을 유효성분으로 함유하는 비만 치료 또는 예방용 약학조성물
KR102656187B1 (ko) 배초향 추출물을 유효성분으로 포함하는 결핵의 예방 또는 치료용 약학 조성물
JP2003012527A (ja) 過食抑制剤
KR20120040890A (ko) 상황버섯균사체 발효 블루베리 추출물의 비만 억제 또는 치료 용도
KR20190084732A (ko) 황태 껍질 발효물을 포함하는 비만 개선, 예방 및 치료용 조성물
JP2023103165A (ja) Ａｔｐ産生促進剤、抗炎症剤及び飲食品
KR20260062484A (ko) 이소사쿠라네틴을 포함하는 당뇨병 예방, 개선 또는 치료용 조성물
US20200206291A1 (en) Composition for preventing or treating obesity, comprising supplement for reducing body fat and b-glucan as active ingredients
KR20210129817A (ko) 벤조피렌 유도체를 유효성분으로 함유하는 체중감소용 조성물
EP2815756A1 (en) Composition for preventing, ameliorating or treating metabolic syndrome
JP2022038319A (ja) インターフェロン－γ産生促進剤

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20121220

Patent event code: PA01051R01D

Comment text: International Patent Application

A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20121224

Comment text: Request for Examination of Application

PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20131128

Patent event code: PE09021S01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20140722

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20150112

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20150202

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20150202

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20171226

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20171226

Start annual number: 4

End annual number: 4